At the same time, I3C pretreatment significantly decreased the expression of the M1 microglial marker IBA1 after cerebral ischemia–reperfusion injury and increased the expression of these results in the M2 microglial marker CD206. Here, MRC1 is linked to Cerebral ischemia.